RARE AND NEW MUTATIONS
OF Β-GLOBIN IN AZARI POPULATION OF IRAN,
A CONSIDERABLE DIVERSITY
Abbasali F.H.1, Mahmoud K.Sh.2,3, Hengameh N.3, Mina D.H.3, Setare D.3, Hale D. M3, Sima D.M.2,3*
*Corresponding Author: MD.PhD Sima Mansoori Derakhshan, Department of Medical Genetics, Faculty
of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran, & Ebne Sina Medical Genetics Laboratory,
Specialized and Sub-specialized Outpatient Clinics, Tabriz
page: 51
|
|
REFERENCES
Birgens, H., Ljung R. The thalassaemia syndromes.
Scand J Clin Lab Invest. 2007; 67(1): 11-26.
2. Weatherall, D. J., Clegg J. B. The thalassaemia syndromes.
John Wiley & Sons; 2008.
3. Abolghasemi, H., Amid A., Zeinali S., Radfar M. H.,
Eshghi P., Rahiminejad M. S., et al. Thalassemia in
Iran: epidemiology, prevention, and management. J
Pediatr Hematol Oncol. 2007; 29(4): 233-8.
4. Najmabadi, H., Karimi-Nejad R., Sahebjam S.,
Pourfarzad F., Teimourian S., Sahebjam F., et al.
The β-thalassemia mutation spectrum in the Iranian
population. Hemoglobin. 2001; 25(3): 285-96.
5. Cao, A., Moi P., Galanello R. Recent advances in
β-thalassemias. Pediatr Rep. 2011; 3(2).
6. Wheatherall DJ, JB. C. The thalassemia syndromes.
England: Blackwell Science Ltd. 2001; 4th ed. Oxford.
7. Rezaee, A. R., Banoei M. M., Khalili E., Houshmand
M. Beta-Thalassemia in Iran: new insight into the
role of genetic admixture and migration. Sci World
J. 2012; 2012.
8. Sarookhani, M. R., Ahmadi M. H. Rare and unexpected
beta thalassemic mutations in Qazvin province
of Iran. Afr J Biotechnol. 2010; 9(1).
9. Taher, A. T., Weatherall D. J., Cappellini M. D. Thalassaemia.
The Lancet. 2018; 391(10116): 155-67.
10. Akhavan-Niaki, H., Derakhshandeh-Peykar P.,
Banihashemi A., Mostafazadeh A., Asghari B., Ahmadifard
M.-R., et al. A comprehensive molecular
characterization of beta thalassemia in a highly heterogeneous
population. Blood Cells Mol Dis. 2011;
47(1): 29-32.
11. Mahdavi, M. R., Karami H., Akbari M. T., Jalali H.,
Roshan P. Detection of Rare Beta Globin Gene Mutation.
Case Rep Hematol. 2013; 2013.
12. Haghi, M., Pouladi N., Hosseinpour Feizi M., Hosseinpour
Feizi A. Β-Thalassemia in Iran. SSU_Journals.
2010; 18(2): 127-33.
13. Haghi, M., Hosseinpour Feizi A. A., Harteveld C. L.,
Pouladi N., Hosseinpour Feizi M. A. Homozygosity
for a rare β0-thalassemia mutation [frameshift codons
25/26 (+ T)] causes β-thalassemia intermedia in an
Iranian family. Hemoglobin. 2009; 33(1): 75-80.
14. Mahdavi, M. R., Karami H., Akbari M. T., Jalali H.,
Roshan P. Detection of rare beta globin gene mutation
[+ 22 5UTR (G> A)] in an infant, despite prenatal
screening. Case Rep Hematol. 2013; 2013.
15. Najmabadi, H., Ghamari A., Sahebjam F., Kariminejad
R., Hadavi V., Khatibi T., et al. Fourteen-year
experience of prenatal diagnosis of thalassemia in
Iran. Public Health Genomics. 2006; 9(2): 93-7.
16. Roudknar, M. H., Najmabadi H., Derakhshandeh P.,
Farhud D. Detection of Rare and Unknown Mutations
in ß-tathalassemia Traits in Iran. Iran J Public Health.
2003: 11-4.
17. Old, J. DNA based diagnosis of the hemoglobin disorders.
Disorders of Hemoglobin: Genetic, Pathophysiology
and Clinical Management Cambridge
University Press, Cambridge, UK. 2001: 941-57.
18. Sima Mansoori Derakhshan, A. K., Abbasali Hosseinpour
Pour Feizi and Mahmoud Shekari Khaniani.
Spectrum of β-Globin Gene Mutations and
β-Thalassemia Haplotype Analysis among the Iranian
Azeri Turkish Population. Epidemiology: Open Access.
2015; 5(4).
19. Samavat, A., Modell B. Iranian national thalassaemia
screening programme. BMJ. 2004; 329(7475): 1134-7.
20. Miri, M., Tabrizi Namini M., Hadipour Dehshal M.,
Sadeghian Varnosfaderani F., Ahmadvand A., Yousefi
Darestani S., et al. Thalassemia in Iran in last twenty years:
the carrier rates and the births trend. 2013; 6(1): 11-7.
21. Teimourian, S., Khatibi T., Pourfarzad F., Jalil-Nejad
S., Azad M. Amplification Refractory Mutation System (ARMS) and reverse hybridizatio n in the
detection of beta-thalassemia mutations. Archives
of Iranian Medicine. 2001; 4(4): 165.
22. Cao, A., Rosatelli M. C., Leoni G. B., Tuveri T.,
Scalas M. T., Monni G., et al. Antenatal Diagnosis
of β‐Thalassemia in Sardiniaa. Ann N Y Acad Sci.
1990; 612(1): 215-25.
23. Alaithan, M. A., AbdulAzeez S., Borgio J. F. A comprehensive
review of the prevalence of beta globin
gene variations and the co-inheritance of related gene
variants in Saudi Arabians with beta-thalassemia.
Saudi Med J. 2018; 39(4): 329.
24. Li, D.-M., He S. Genotypes of thalassemia in children:
an analysis of 30 417 cases. Zhongguo Dang
dai er ke za zhi= Chinese Journal of Contemporary
Pediatrics. 2021; 23(8): 841-7.
25. Altay, C. The Frequency and Distribution Pattern of
ss-Thalassemia Mutations in Turkey. Turk J Haematol.
2002; 19(2): 309-15.
26. Kadhim, K. A., Baldawi K. H., Lami F. H. Prevalence,
Incidence, Trend, and Complications of Thalassemia
in Iraq. Hemoglobin. 2017; 41(3): 164-8. doi:
10.1080/03630269.2017.1354877.
27. Gaziev, D. Thalassaemia in Azerbaijan. J Med Genet.
1995; 32(3): 245.
28. Kuliev, A. M., Rasulov I. M., Dadasheva T., Schwarz
E. I., Rosatelli C., Saba L., et al. Thalassaemia in
Azerbaijan. J Med Genet. 1994; 31(3): 209-12.
29. Yasmeen, H., Toma S., Killeen N., Hasnain S., Foroni
L. The molecular characterization of Beta globin gene
in thalassemia patients reveals rare and a novel mutations
in Pakistani population. Eur J Med Genet. 2016;
59(8): 355-62. doi: 10.1016/j.ejmg.2016.05.016.
30. Derakhshandeh-Peykar, P., Akhavan-Niaki H., Tamaddoni
A., Ghawidel-Parsa S., Naieni K. H., Rahmani
M., et al. Distribution of beta-thalassemia mutations
in the northern provinces of Iran. Hemoglobin. 2007;
31(3): 351-6.
31. Galehdari, H., Pedram M., Salehi B., Andashti B.
Wide Spectrum of Mutations in the Beta-Globin Gene
Causing Beta-Thalassemia Major in Southwest Iran.
Iranian Journal of Pediatric Society. 2010; 1(3): 12-6.
32. Derakhshandeh-Peykar, P., Hourfar H., Heidari M.,
Kheirollahi M., Miryounesi M. The Spectrum of β
-thalassemia Mutations in Isfahan Province of Iran.
Iran J Public Health. 2008; 37(2).
33. Esteghamat, F., Imanian H., Azarkeivan A., Pourfarzad
F., Almadani N., Najmabadi H. Screening of
Iranian thalassemic families for the most common
deletions of the β-globin gene cluster. Hemoglobin.
2007; 31(4): 463-9.
34. Mahdieh, N., Rabbani B. Beta thalassemia in 31,734
cases with HBB gene mutations: Pathogenic and
structural analysis of the common mutations; Iran as
the crossroads of the Middle East. Blood Rev. 2016;
30(6): 493-508. doi: 10.1016/j.blre.2016.07.001.
35. Galehdari, H., Salehi B., Pedram M., Oraki Kohshour
M. High prevalence of rare mutations in the Beta globin
gene in an ethnic group in iran. Iran Red Crescent
Med J. 2011; 13(5): 356-8.
36. Thein, S. L. The molecular basis of beta-thalassemia.
Cold Spring Harb Perspect Med. 2013; 3(5): a011700.
doi: 10.1101/cshperspect.a011700.
37. Najmabadi, H., Pourfathollah A. A., Neishabury M.,
Sahebjam F., Krugluger W., Oberkanins C. Rare and
unexpected mutations among Iranian beta-thalassemia
patients and prenatal samples discovered by
reverse-hybridization and DNA sequencing. Haematologica.
2002; 87(10): 1113-4.
38. Roudknar, M. H., Najmabadi H., Derakhshandeh P.,
Farhud D. Detection of Rare and Unknown Mutations
in??-tathalassemia Traits in Iran. Iran J Public Health.
2003; 32(1): 11-4.
39. Rahimi, Z., Karimi M., Haghshenass M., Merat A.
beta-globin gene cluster haplotypes in sickle cell
patients from southwest Iran. Am J Hematol. 2003;
74(3): 156-60.
40. Yavarian, M. Hemoglobinopathies in Iran; molecular
spectrum, prevention and treatment: Leiden University,
Leiden University Medical Center, Dept. of
Hematology; 2005.
41. Ayçiçek, A., Koç A., Özdemir Z. C., Bilinç H.,
Koçyigit A., Dilmeç F. Beta-globin gene mutations
in children with beta-thalassemia major from Sanliurfa
province, Turkey/Türkiye, Sanliurfa bölgesinde
talasemi majorlü çocuk hastalarda beta-globin gen
mutasyonlari. Turkish Journal of Haematology. 2011;
28(4): 264.
42. Zahed, L. The Spectrum of beta-Thalassemia Mutations
in the Arab Populations. J Biomed Biotechnol.
2001; 1(3): 129-32.
43. Jaripour, M. E., Hayatigolkhatmi K., Iranmanesh V.,
Zand F. K., Badiei Z., Farhangi H., et al. Prevalence of
beta-Thalassemia Mutations among Northeastern Iranian
Population and their Impacts on Hematological
Indices and Application of Prenatal Diagnosis, a Seven-
Years Study. Mediterr J Hematol Infect Dis. 2018;
10(1): e2018042. doi: 10.4084/MJHID.2018.042.44. Rahbar, S., Asmerom Y., Blume K. G. A silent hemoglobin
variant detected by HPLC: Hemoglobin City
of Hope β69 (E13) Gly→ Ser. Hemoglobin. 1984;
8(4): 333-42.
45. Delanoe-Garin, J., Arous N., Blouquit Y., Hafsia
R., Bardakdjian J., Lacombe C., et al. Hemoglobin
Kenitra α2β269 (E13) Gly→ Arg. A new β variant
of elevated expression associated with α-thalassemia,
found in a Moroccan woman. Hemoglobin. 1985;
9(1): 1-9.
46. Sick, K., Beale D., Irvine D., Lehmann H., Goodall
P., MacDougall S. Haemoglobin GCopenhagen and
haemoglobin JCambridge. Two new β-chain variants
of haemoglobin A. Biochimica et Biophysica Acta
(BBA)-Protein Structure. 1967; 140(2): 231-42.
47. Vinciguerra, M., Passarello C., Leto F., Cassarà F.,
Cannata M., Maggio A., et al. Co‐inheritance of the
rare β hemoglobin variants Hb Yaounde, Hb Görwihl
and Hb City of Hope with other alterations in globin
genes: impact in genetic counseling. EUR J HAEMATOL.
2015; 94(4): 322-9.
48. Vinciguerra, M., Passarello C., Cassarà F., Leto F.,
Cannata M., Calvaruso G., et al. Co‐heredity of silent
CAP+ 1570 T> C (HBB: c* 96T> C) defect and
severe β‐thal mutation: a cause of mild β‐thalassemia
intermedia. Int J Lab Hematol. 2016; 38(1): 17-26.
49. Pagano, L., Viola A., Fioretti G., Ammirabile M., Ricchi
P., Prossomariti L. Neapolis (CD 126 β+ GTG→
GGG): a result of a screening in Campania, a region
in Southern Italy. Haematologica. 2007; 92(7): 990-1.
50. Weatherall, D. Phenotype—genotype relationships in
monogenic disease: lessons from the thalassaemias.
Nat Rev Genet. 2001; 2(4): 245-55.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
